Xeno Transplants Corporation (XENO)

Market Cap	4.04K
Revenue (ttm)	n/a
Net Income (ttm)	-256.37K
Shares Out	40.36M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Average Volume	25,302
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-42.14
RSI	38.12
Earnings Date	n/a

About Xeno Transplants

Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from oth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: XENO